TR200100637T2 - Yeni doğal ürün türevleri - Google Patents

Yeni doğal ürün türevleri

Info

Publication number
TR200100637T2
TR200100637T2 TR2001/00637T TR200100637T TR200100637T2 TR 200100637 T2 TR200100637 T2 TR 200100637T2 TR 2001/00637 T TR2001/00637 T TR 2001/00637T TR 200100637 T TR200100637 T TR 200100637T TR 200100637 T2 TR200100637 T2 TR 200100637T2
Authority
TR
Turkey
Prior art keywords
natural product
new natural
product derivatives
derivatives
new
Prior art date
Application number
TR2001/00637T
Other languages
English (en)
Inventor
Brands Michael
Es-Sayed Mazen
Habich Dieter
Raddatz Siegfried
Kr�ger Joachim
Endermann Rainer
Gahlmann Reinhold
Kroll Hein-Peter
Geschke Frank-Ulrich
De Meijere Armin
N. Belov Vladimir
Sokolov Victor
Kozhushkov Sergej
Kordes Markus
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR200100637T2 publication Critical patent/TR200100637T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Abstract

Bulus, yeni dogal ürün türevlerine, bunlarin hazirlanmasi için islemlere, bu türevleri içeren farmasötik bilesimlere ve insanlarda ve hayvanlarda hastaliklarin tedavisi için kullanilmalarina iliskindir.
TR2001/00637T 1998-08-27 1999-08-20 Yeni doğal ürün türevleri TR200100637T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19838998A DE19838998A1 (de) 1998-08-27 1998-08-27 Neue Naturstoffderivate

Publications (1)

Publication Number Publication Date
TR200100637T2 true TR200100637T2 (tr) 2001-10-22

Family

ID=7878913

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00637T TR200100637T2 (tr) 1998-08-27 1999-08-20 Yeni doğal ürün türevleri

Country Status (25)

Country Link
US (1) US6617332B1 (tr)
EP (1) EP1117652B1 (tr)
JP (1) JP4533535B2 (tr)
KR (1) KR20010099629A (tr)
CN (1) CN1324348A (tr)
AT (1) ATE267816T1 (tr)
AU (1) AU759618B2 (tr)
BG (1) BG105275A (tr)
BR (1) BR9913337A (tr)
CA (1) CA2342102C (tr)
DE (2) DE19838998A1 (tr)
EE (1) EE200100125A (tr)
ES (1) ES2219105T3 (tr)
HK (1) HK1041884A1 (tr)
HR (1) HRP20010135A2 (tr)
HU (1) HUP0103316A3 (tr)
ID (1) ID28365A (tr)
IL (1) IL141325A0 (tr)
NO (1) NO20010940L (tr)
NZ (1) NZ510153A (tr)
PL (1) PL346143A1 (tr)
SK (1) SK2622001A3 (tr)
TR (1) TR200100637T2 (tr)
WO (1) WO2000012484A1 (tr)
ZA (1) ZA200101038B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113008A1 (en) * 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
US20040204404A1 (en) * 2002-09-30 2004-10-14 Robert Zelle Human N-type calcium channel blockers
EP2220093A4 (en) * 2007-12-20 2011-06-22 Reddys Lab Ltd Dr METHOD FOR THE PRODUCTION OF SITAGLIPTIN AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
EP2489655A4 (en) 2009-10-15 2014-03-12 Univ Tokushima PROCESS FOR PREPARING DIETHYLENE-TRIAMIN-PENTA-ACETIC DERIVATIVES AND DIETHYLENE-TRIAMIN-PENTA-ACETIC ACID DERIVATIVES
EA201270568A1 (ru) 2009-10-16 2012-11-30 Риб-Экс Фармасьютикалз, Инк. Антимикробные композиции и способы их получения и применения
CN107266470A (zh) * 2009-10-16 2017-10-20 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
US9193731B2 (en) 2009-10-16 2015-11-24 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CA2777741A1 (en) 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
MX357903B (es) 2011-04-15 2018-07-30 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de formación y uso de los mismos..
RU2475479C1 (ru) * 2011-12-23 2013-02-20 Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) Вазоконстрикторное средство
KR20160070066A (ko) 2013-09-09 2016-06-17 멜린타 테라퓨틱스, 인크. 항균 화합물, 및 이의 제조 방법 및 이용 방법
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
SG11201707346RA (en) 2015-03-11 2017-10-30 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途
CA2297055A1 (en) 1997-08-07 1999-02-18 Research Corporation Technologies, Inc. Antibiotic for methicillin resistant bacteria

Also Published As

Publication number Publication date
ID28365A (id) 2001-05-17
JP2002523496A (ja) 2002-07-30
ATE267816T1 (de) 2004-06-15
ES2219105T3 (es) 2004-11-16
KR20010099629A (ko) 2001-11-09
SK2622001A3 (en) 2001-11-06
NZ510153A (en) 2002-12-20
JP4533535B2 (ja) 2010-09-01
CA2342102A1 (en) 2000-03-09
AU1009900A (en) 2000-03-21
EE200100125A (et) 2002-06-17
NO20010940D0 (no) 2001-02-23
NO20010940L (no) 2001-04-23
DE59909607D1 (de) 2004-07-01
CN1324348A (zh) 2001-11-28
AU759618B2 (en) 2003-04-17
US6617332B1 (en) 2003-09-09
EP1117652A1 (de) 2001-07-25
HK1041884A1 (zh) 2002-07-26
HRP20010135A2 (en) 2002-02-28
HUP0103316A2 (hu) 2002-04-29
DE19838998A1 (de) 2000-03-09
CA2342102C (en) 2008-10-28
HUP0103316A3 (en) 2002-06-28
BR9913337A (pt) 2001-05-15
BG105275A (en) 2001-11-30
ZA200101038B (en) 2002-02-07
WO2000012484A1 (de) 2000-03-09
EP1117652B1 (de) 2004-05-26
PL346143A1 (en) 2002-01-28
IL141325A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
TR199901174T2 (tr) Yeni heterosiklilmetil-ikameli pirazol türevleri.
TR199901172T2 (tr) Yeni ikame edilmis pirazol türevleri.
NO20061736L (no) Krystallform av epotilon B
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de) Thiazolopyrimidinderivate
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
TR200101649T2 (tr) Piperazin türevleri.
TR200100637T2 (tr) Yeni doğal ürün türevleri
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
DK0823903T3 (da) Heterocykliske biarylforbindelser, farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem, og anvendelser
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
TR200003596T2 (tr) Hipnotik beta-karbolin türevleri,hazırlanmaları için işlem ve tıbbi ürün olarak kullanımları
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
MX9805065A (es) Nuevos derivados bi-aromaticos del dibenzofurano y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
TR199901385T2 (tr) Piperidin türevleri.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
TR200003301T2 (tr) Morfolino eterler
TR200000916T2 (tr) İkameli piperidin türevleri.
SE9803277D0 (sv) Novel compounds